80% of rare diseases remain undiagnosed worldwide, leaving millions without answers. My Genome Screen enhances diagnostic accuracy through specialized variant prioritization algorithms powered by AI. By identifying the most relevant genetic variants, we help clinicians make faster, more precise rare disease diagnoses. Eventually, we aim to help diagnose millions of undetected cases annually.

Rare disease patients face an average 5-year diagnostic journey, often seeing 8 or more doctors along the way. My Genome Screen accelerates this process with AI-powered variant prioritization, helping clinicians pinpoint disease-causing mutations faster. We bring patients closer to answers and life-changing treatments much sooner.

Early genetic diagnosis doesn’t just improve treatment—it transforms outcomes. Studies show it can increase survival rates by 30% and enable preventive strategies that stop diseases before they develop. My Genome Screen helps detect risks earlier, equipping clinicians with life-saving insights to guide both treatment and prevention before symptoms even appear. It also offers carrier screening for parents before pregnancy, identifying risks for many inherited diseases early on.